SEC Form 4 · accession 0000911916-18-000026

ZIMMER BIOMET HOLDINGS, INC. · ZBH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. VP/Gen Counsel/Secretary

Period of report

Feb 12, 2018

Accepted (ET)

Feb 14, 2018 · 9:35 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001136869

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 12, 2018	M	27,000	$78.53	A	63,843	D
Common Stock^F2	Feb 12, 2018	S	12,454	$115.6365	D	51,389	D
Common Stock^F3	Feb 12, 2018	S	8,372	$116.4139	D	43,017	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$78.53	Feb 12, 2018	M	27,000	D	—	Feb 12, 2018	Common Stock	27,000	0	D

F1Includes 148 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and January 30, 2018 and 198 shares purchased between July 28, 2017 and January 29, 2018 under the dividend reinvestment plan for the Company's common stock.
F2Represents the sale of 12,454 shares in multiple transactions, ranging in price from $115.05 to $116.04 per share, resulting in a weighted average sale price of $115.6365. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F3Represents the sale of 8,372 shares in multiple transactions, ranging in price from $116.05 to $116.78 per share, resulting in a weighted average sale price of $116.4139. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
F4Vested annually over four years in increments of 25% each year, commencing on February 12, 2009.